Black Diamond Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
Black Diamond Therapeutics last closed at $1.83 (+1.10%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -2.4×. Its overall grade ranks 525 of 738 stocks in Healthcare.
About this company
Black Diamond Therapeutics last closed at $1.83 (+1.10%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 525/738
Valuation grade B+
Related stocks
- AstraZenecaCompetitor
항암제 개발 분야의 글로벌 대형 제약사로, 정밀의학·종양 치료제 경쟁 구도에서 비교 대상
- MerckCompetitor
면역항암제·종양 치료제의 대표 대형 경쟁사
- Bristol Myers SquibbCompetitor
종양·혈액암 치료제 강자로서 항암 신약 개발 경쟁사
About Black Diamond Therapeutics
- What technical signals does Black Diamond Therapeutics (BDTX) have?
- Black Diamond Therapeutics current technical signals: no active technical signal.
- Is Black Diamond Therapeutics a cup-and-handle pattern?
- No. Black Diamond Therapeutics has no valid Cup signal right now.
- What published figures are available for Black Diamond Therapeutics?
- Market cap: $104.26M. Trailing 12 months PER: -2.4×. Latest quarter PBR: 1.08×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Black Diamond Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.